Smith Group Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,000
Closed -$306K 182
2024
Q4
$306K Buy
+2,000
New +$337K 0.02% 172
2020
Q2
Sell
-113,878
Closed -$36M 307
2020
Q1
$36M Sell
113,878
-28,543
-20% -$8.66M 1.97% 11
2019
Q4
$42.3M Sell
142,421
-45,972
-24% -$12.8M 1.77% 11
2019
Q3
$43.8M Sell
188,393
-43,919
-19% -$10.2M 1.54% 15
2019
Q2
$54.3M Buy
232,312
+22,507
+11% +$5.2M 1.82% 12
2019
Q1
$49.6M Buy
209,805
+94,314
+82% +$29.7M 1.61% 16
2018
Q4
$34.9M Buy
115,491
+27,672
+32% +$8.83M 1.23% 23
2018
Q3
$30.5M Sell
87,819
-3,581
-4% -$1.23M 0.87% 43
2018
Q2
$26.8M Sell
91,400
-126,807
-58% -$35.7M 0.78% 52
2018
Q1
$59.7M Sell
218,207
-4,872
-2% -$1.51M 1.97% 12
2017
Q4
$71.2M Buy
223,079
+138,832
+165% +$44.5M 2.24% 9
2017
Q3
$26.4M Buy
+84,247
New +$24.9M 0.88% 39
2015
Q2
Sell
-17,770
Closed -$7.5M 403
2015
Q1
$7.5M Hold
17,770
0.25% 92
2014
Q4
$6.03M Buy
17,770
+20
+0.1% +$6.47K 0.21% 98
2014
Q3
$5.87M Buy
17,750
+100
+0.6% +$33K 0.22% 100
2014
Q2
$5.57M Hold
17,650
0.21% 98
2014
Q1
$5.4M Hold
17,650
0.21% 97
2013
Q4
$4.93M Hold
17,650
0.19% 98
2013
Q3
$4.25M Hold
17,650
0.18% 97
2013
Q2
$3.8M Buy
+17,650
New +$3.77M 0.16% 113

Other funds holding BIIB

Smith Group Asset Management's BIIB Position: Q1 2025 in Review

Smith Group Asset Management sold out of Biogen (BIIB) in Q1 2025, closing a stake of 2,000 shares — an estimated $306K sold.

Smith Group Asset Management first reported a position in BIIB in Q2 2013 and held it in 20 quarters. The position peaked at $71.2M in Q4 2017. 882 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

  • Smith Group Asset Management reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
  • Smith Group Asset Management sold 2,000 Biogen shares in Q1 2025, an estimated $306K.
  • Smith Group Asset Management first reported a position in Biogen in Q2 2013 and held it in 20 quarters.
  • Smith Group Asset Management's Biogen position peaked at $71.2M in Q4 2017.
  • 882 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Smith Group Asset Management's 13F filing for Q1 2025, filed 28 Apr 2025.